Search Results - "Chernaya, Valeria"
-
1
Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function
Published in Journal of hematology and oncology (31-10-2014)“…Endothelial dysfunction is a pathological status of the vascular system, which can be broadly defined as an imbalance between endothelium-dependent…”
Get full text
Journal Article -
2
Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy
Published in Journal of hematology and oncology (11-04-2015)“…As the population ages and lifestyles change in concordance, the number of patients suffering from ischemic stroke and its associated disabilities is…”
Get full text
Journal Article -
3
The expressions of 164 histone modification enzymes in seven groups are modulated in respond to pathogenic processes of metabolic diseases, tumors and regulatory T cell differentiation
Published in The Journal of immunology (1950) (01-05-2017)“…Abstract To determine whether the expression of histone modification enzymes is regulated in physiological and pathological conditions, we took an experimental…”
Get full text
Journal Article -
4
Epigenetic enzymes are the therapeutic targets for CD4(+)CD25(+/high)Foxp3(+) regulatory T cells
Published in Translational research : the journal of laboratory and clinical medicine (01-01-2015)“…CD4(+)CD25(+/high)Foxp3(+) regulatory T (Treg) cells are a subset of CD4(+) T cells that play an essential role in maintaining peripheral immune tolerance…”
Get full text
Journal Article -
5
Epigenetic Enzymes are Replaced in Atherogenesis and Regulatory T Cell Conversion by Groups of Upregulated Enzymes
Published in The FASEB journal (01-04-2015)“…Abstract only…”
Get full text
Journal Article -
6
Metabolic Diseases Downregulate the Majority of Histone Modification Enzymes, Making a Few Upregulated Enzymes Novel Therapeutic Targets—“Sand Out and Gold Stays”
Published in Journal of cardiovascular translational research (01-02-2016)“…To determine whether the expression of histone modification enzymes is regulated in physiological and pathological conditions, we took an experimental database…”
Get full text
Journal Article -
7
Epigenetic enzymes are the therapeutic targets for CD4+CD25+/highFoxp3+ regulatory T cells
Published in Translational research : the journal of laboratory and clinical medicine (01-01-2015)“…CD4+CD25+/highFoxp3+ regulatory T (Treg) cells are a subset of CD4+ T cells that play an essential role in maintaining peripheral immune tolerance. Several…”
Get full text
Journal Article -
8
Epigenetic enzymes are the therapeutic targets for CD4+ CD25+/high Foxp3+ regulatory T cells
Published in Translational research : the journal of laboratory and clinical medicine (2015)“…CD4+ CD25+/high Foxp3+ regulatory T (Treg) cells are a subset of CD4+ T cells that play an essential role in maintaining peripheral immune tolerance. Several…”
Get full text
Journal Article